Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Capital Employed (2016 - 2026)

Biomerica's Return on Capital Employed history spans 16 years, with the latest figure at 137.43% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 18174.0% to 137.43% in Q1 2026 year-over-year; TTM through Feb 2026 was 137.43%, a 18174.0% decrease, with the full-year FY2025 number at 87.67%, down 10059.0% from a year prior.
  • Return on Capital Employed hit 137.43% in Q1 2026 for Biomerica, down from 108.67% in the prior quarter.
  • Over the last five years, Return on Capital Employed for BMRA hit a ceiling of 44.31% in Q1 2025 and a floor of 137.43% in Q1 2026.
  • Historically, Return on Capital Employed has averaged 53.12% across 5 years, with a median of 59.11% in 2023.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 11771bps in 2025 and later crashed -18174bps in 2026.
  • Tracing BMRA's Return on Capital Employed over 5 years: stood at 64.25% in 2022, then rose by 8bps to 59.11% in 2023, then skyrocketed by 151bps to 30.28% in 2024, then crashed by -459bps to 108.67% in 2025, then dropped by -26bps to 137.43% in 2026.
  • Business Quant data shows Return on Capital Employed for BMRA at 137.43% in Q1 2026, 108.67% in Q4 2025, and 103.79% in Q3 2025.